fbpx
    • Myeloma Crowd Newsroom
    • Uncategorized
    • Mar 05, 2014

    Cure Panel Features Jenny Ahlstrom’s Journey of Myeloma Survivorship

image_print

jenny-bio-100x100Myeloma Crowd founder, Jenny Ahlstrom, is featured in Cure Panel’s newsletter. Read about her journey here.

About Author

Jenny A

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.

Leave A Comment

CAPTCHA

Please enter the correct captcha code to verify that you are human.

MYELOMA CROWD RESEARCH INITIATIVE
$165328 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal

AmazonSmile
More Articles
bone damage

IMW Life With Multiple Myeloma

Earlier Detection of Multiple Myeloma Prevents Bone Damage and Extends Life

Oct 07, 2019

Earlier detection of multiple myeloma before bone damage occurs extends lives, according to a Swedish study presented at the 17th International Myeloma Workshop.  In the study, researchers used the Swedish Cancer Register to gather information on 14,013 myeloma patients such as birthdate, myeloma diagnosis date, fractures and death dates. A model was used to estimate […]

Multiple Myeloma News

New Strategies to Improve CAR-T Therapies for Multiple Myeloma

Oct 08, 2019

A short but very interesting paper has just been published in the journal Blood Advances that provides insights as to why some multiple myeloma patients have better outcomes than others when treated with anti-BCMA CAR-T. The authors start the paper with a bang: ‘Chimeric antigen receptor (CAR) T cells are a promising, emerging therapy for […]

IMW Myeloma Clinical Trials

IMW 2019: A Vaccine to Extend Myeloma Remissions with Syed Abbas Ali, MD

Sep 19, 2019

When should myeloma vaccines be used for patients? Dr. Syed Abbas Ali, MD of Johns Hopkins Medicine tells us that it’s usually when there is a low tumor burden, like after stem cell transplant or when patients are on maintenance and their myeloma is under control.  Dr. Ali shares his Phase II study of a […]

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors: